How we diagnose and treat systemic mastocytosis in adults.

about

Incidence, racial disparities and survival outcomes of mast cell malignancies: analysis from a national database.Coexistence of urticaria pigmentosa and thalassemia minor in a young adult.Mast cell deposition and activation may be a new explanation for epiploic appendagitis

P2860

Q48319528-EE067520-6878-410D-B135-9E43E5B58E37 Q55000378-6CAE69DD-A8B2-4E4F-AA7A-94598C6B50BF Q58701921-5B0D9013-25A4-4FD2-ABFC-9DC7C513243C

P2860

How we diagnose and treat systemic mastocytosis in adults.

Item

http://www.wikidata.org/entity/Q47763014

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

How we diagnose and treat systemic mastocytosis in adults.

@en

How we diagnose and treat systemic mastocytosis in adults.

@nl

type

Item

label

How we diagnose and treat systemic mastocytosis in adults.

@en

How we diagnose and treat systemic mastocytosis in adults.

@nl

prefLabel

How we diagnose and treat systemic mastocytosis in adults.

@en

How we diagnose and treat systemic mastocytosis in adults.

@nl

P1476

How we diagnose and treat systemic mastocytosis in adults.

@en

P2093

Robyn M Scherber

http://www.w3.org/2001/XMLSchema#string

Uma Borate

http://www.w3.org/2001/XMLSchema#string

P2860

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

Reports of Medical and Surgical Practice in the Hospitals of Great Britain

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Advances in the understanding and clinical management of mastocytosis and clonal mast cell activation syndromes

CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy

Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis

Mastocytosis.

Mast cell-mediated and associated disorders in pregnancy: a risky game with an uncertain outcome?

Diagnostic criteria and classification of mastocytosis: a consensus proposal.

Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease.

P304

11-23

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BJH.14967

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

180

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29048112

http://www.w3.org/2001/XMLSchema#string

How we diagnose and treat systemic mastocytosis in adults.

about

P2860

P2860

How we diagnose and treat systemic mastocytosis in adults.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698